Spidia-RNA: Second external quality assessment for the Pre-Analytical Phase of Blood Samples Used for RNA Based Analyses.

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Malentacchi, Francesca ^a   Pazzagli, Mario ^a   Simi, Lisa ^a   Orlo, Claudio ^a   Wyrich, Ralf ^b   Guünther, Kalle ^b   Verderio, Paolo ^c   Pizzamiglio, Sara ^c   Ciniselli, Chiara Maura ^c   Zhang, Hui ^d   Korenková, Vlasta ^e   Rainen, Lynne ^f   Bar, Tzachi ^g   Kubista, Mikael ^e,h   Gelmini, Stefania ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b QIAGEN GMBH   (Germany)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d DiaGenic AS   (Norway)

^e INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^f BD Technologies   (United States)

^g Labonnet Ltd St Ramat Hasharon   (Israel)

^h TATAA Biocenter AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROTEIN FOS; RNA; TRANSCRIPTION FACTOR FOSB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; FOSB PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PROTEIN C FOS; TNFRSF10C PROTEIN, HUMAN; TUMOR NECROSIS FACTOR DECOY RECEPTOR;

ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CLINICAL PROTOCOL; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; GENE EXPRESSION; HUMAN; LABORATORY TEST; MATERIALS HANDLING; MOLECULAR GENETICS; PRACTICE GUIDELINE; QUALITY CONTROL; RNA ANALYSIS; RNA EXTRACTION; RNA PURIFICATION; RNA STABILITY; STORAGE TEMPERATURE; VALIDATION PROCESS; BLOOD; GENE EXPRESSION PROFILING; GENETICS; PROCEDURES;

BLOOD SPECIMEN COLLECTION; GENE EXPRESSION PROFILING; GPI-LINKED PROTEINS; HUMANS; INTERLEUKIN-1BETA; PROTO-ONCOGENE PROTEINS C-FOS; QUALITY CONTROL; RNA; TUMOR NECROSIS FACTOR DECOY RECEPTORS;

EID: 84911422161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112293     Document Type: Article

References (19)

1. Pazzagli M, Malentacchi F, Simi L, Orlando C, Wyrich R, et al. (2013) SPIDIARNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. Methods 59: 20-31.
2. Malentacchi F, Pazzagli M, Simi L, Orlando C, Wyrich R, et al. (2013) SPIDIADNA: An External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. Clin Chim Acta 25: 274-286.
3. Bustin SA (2010) Why the need for qPCR publication guidelines? - The case for MIQE. Methods 50: 217-26.
4. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, et al. (2002) Stabilization of mRNA expression in whole blood samples. Clin Chem 48:1883-90.
5. Tichopad A, Bar T, Pecen T, Kitchen RR, Kubista M, et al. (2010) Quality control for quantitative PCR based on amplification compatibility test. Methods 308-12.
6. Kim SJ, Dix DJ, Thompson KE, Murrell RN, Schmid JE, et al. (2007) Effects of storage, RNA extraction, genechip type, and donor sex on gene expression profiling of human whole blood. Clin Chem 53: 1038-45.
7. Pahl A, Brune K (2002) Gene expression changes in blood after phlebotomy: implications for gene expression profiling. Blood 100: 1094-95.
8. Ha? rtel C, Bein G, Mu?ller-Steinhardt M, Klu?ter H (2001) Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods 249: 63-71.
9. McCulloch CE, Searle SR (2001) Generalized, Linear, and mixed models. New York: John Wiley & Sons. 281-284.
10. Gu?nther K, Malentacchi F, Verderio P, Pizzamiglio S, Ciniselli CM, et al. (2012) Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. Clinica Chimica Acta 413: 779-86.
11. Efron B, Tibshirana RJ (1993) An Introduction to the Bootstrap. London: Chapman and Hall 436pp.
12. Iglewicz B, Hoaglin DC (1993) How to Detect and Handle Outliers. In: ASCQ Quality Press, Milwaukee, 87pp.
13. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using Real Time Quantitative PCR and the 22DDCt methods. Methods 25: 402-8.
14. Laurell H, Iacovoni JS, Abot A, Svec D, Maoret JJ, et al. (2012) Correction of RT-qPCR data for genomic DNA-derived signals with ValidPrime.Nucleic Acid Res 40: e51.
15. Fleige S, Pfaffl M (2006) RNA integrity and the effect on the real-time qRTPCR performance. Molecular Aspects of Medicine 27: 126-39.
16. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, et al. (2006) Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR.Biotechnol. Let 28: 1601-13.
17. Nussbaumer C, Gharehbaghi-Schnell E, Korschineck I (2006) Messanger RNA profiling: a novel method for body fluid identification by real-time PCR. Forensic science international 157: 181-6.
18. Ovstebo R, Lande K, Kierulf P, Haug KBF (2007) Quantification of relative change in specific mRNA from frozen whole blood-methodological considerations and clinical implications. Clin Chim Med 45: 171-6.
19. Madej RM, Cao Z, Hall L, Neuwald PD, Williams LO (2005) Proficiency testing (external quality assessment) for molecular methods, approved guideline. CLSI document MM14-A, Vol. 25, No. 24. Clinical and Laboratory Standards Institute; 1-51.